Hold Jyothy Laboratories; target of Rs 150: ICICI Direct

ICICI Direct recommended hold rating on Jyothy Laboratories with a target price of Rs 150 in its research report dated November 06, 2020.

Hold Jyothy Laboratories; target of Rs 150: ICICI Direct

ICICI Direct recommended hold rating on Jyothy Laboratories with a target price of Rs 150 in its research report dated August 06, 2020.

Buy Jyothy Laboratories; target of Rs 170: Sharekhan

Sharekhan is bullish on Jyothy Laboratories has recommended buy rating on the stock with a target price of Rs 170 in its research report dated August 05, 2020.

Neutral Jyothy Laboratories; target of Rs 135: Motilal Oswal

Motilal Oswal recommended neutral rating on Jyothy Laboratories with a target price of Rs 135 in its research report dated August 05, 2020.

Buy Jyothy Laboratories; target of Rs 140: Sharekhan

Sharekhan is bullish on Jyothy Laboratories has recommended buy rating on the stock with a target price of Rs 140 in its research report dated June 05, 2020.

Hold Jyothy Laboratories; target of Rs 115: ICICI Direct

ICICI Direct recommended hold rating on Jyothy Laboratories with a target price of Rs 115 in its research report dated June 06, 2020.

Buy Jyothy Laboratories; target of Rs 140: Sharekhan

Sharekhan is bullish on Jyothy Laboratories has recommended buy rating on the stock with a target price of Rs 140 in its research report dated June 05, 2020.

Hold Jyothy Laboratories; target of Rs 185: ICICI Direct

ICICI Direct recommended Hold rating on Jyothy Laboratories with a target price of Rs 185 in its research report dated October 23, 2019.

Jyothy Laboratories Q2 PAT may dip 0.1% YoY to Rs. 45.3 cr: Kotak

Net Sales are expected to increase by 6.5 percent Y-o-Y (up 10.7 percent Q-o-Q) to Rs. 455.5 crore, according to Kotak.

Hold Jyothy Laboratories; target of Rs 180: ICICI Direct

ICICI Direct recommended hold rating on Jyothy Laboratories with a target price of Rs 180 in its research report dated July 24, 2019.

Hold Jyothy Laboratories; target of Rs 180: Sharekhan

Sharekhan recommended Hold rating on Jyothy Laboratories with a target price of Rs 180 in its research report dated July 23, 2019.

Jyothy Laboratories Q1 PAT seen up 25.1% YoY to Rs. 40.5 cr: ICICI Direct

Net Sales are expected to increase by 7.1 percent Y-o-Y (down 14.5 percent Q-o-Q) to Rs. 431.2 crore, according to ICICI Direct.

Hold Jyothy Laboratories; target of Rs 180: Sharekhan

Sharekhan recommended Hold rating on Jyothy Laboratories with a target price of Rs 180 in its research report dated June 24, 2019.

3 Point Analysis | Jyothy Laboratories Q4 review

Sakshi Batra does a 3 Point Analysis of the key highlights of Q4 earnings and the outlook on the company.

Buy Jyothy Laboratories; target of Rs 220: ICICI Direct

ICICI Direct is bullish on Jyothy Laboratories has recommended buy rating on the stock with a target price of Rs 220 in its research report dated May 09, 2019.

Hold Jyothy Laboratories; target of Rs 195: Sharekhan

Sharekhan recommended Hold rating on Jyothy Laboratories with a target price of Rs 195 in its research report dated May 07, 2019.

Jyothy Labs Q4 net profit up 11% at Rs 67.05 cr

The company had posted a net profit of Rs 60.35 crore in January-March period a year ago, it said in a statement.

Jyothy Labs Standalone March 2019 Net Sales at Rs 504.29 crore, down 0.22% Y-o-Y

Jyothy Laboratories Q4 PAT may dip 7.4% YoY to Rs. 55.9 cr: ICICI Direct

Net Sales are expected to increase by 9.7 percent Y-o-Y (up 20.5 percent Q-o-Q) to Rs. 523.5 crore, according to ICICI Direct.

Jyothy Labs jumps 5% after Macquarie initiates coverage with outperform call

Macquarie said it likes company's diverse product portfolio with a presence in mainstay categories.

Buy Jyothy Laboratories; target of Rs 225: Sharekhan

Sharekhan is bullish on Jyothy Laboratories has recommended buy rating on the stock with a target price of Rs 225 in its research report dated January 24, 2019.

Buy Jyothy Laboratories; target of Rs 240: ICICI Direct

ICICI Direct is bullish on Jyothy Laboratories has recommended buy rating on the stock with a target price of Rs 240 in its research report dated January 25, 2019.

Jyothy Labs Q3 net rises 29.85% at Rs 48.41 crore

The company had posted a net profit of Rs 37.28 crore during the same period previous fiscal, it said in a statement.

Jyothy Labs Standalone December 2018 Net Sales at Rs 434.33 crore, up 3.81% Y-o-Y

Jyothy Laboratories (Standalone) Q3 PAT seen up 18.1% YoY to Rs. 44 cr: Kotak

Net Sales are expected to increase by 10 percent Y-o-Y (up 7.6 percent Q-o-Q) to Rs. 460.2 crore, according to Kotak.